US Patent Issued to Medilabo RFP on Jan. 13 for "Prophylactic or therapeutic drug for neurodegenerative diseases" (Japanese Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,387, issued on Jan. 13, was assigned to Medilabo RFP Inc. (Tokyo).

"Prophylactic or therapeutic drug for neurodegenerative diseases" was invented by Takami Tomiyama (Osaka, Japan), Tomohiro Umeda (Osaka, Japan) and Toru Kumagai (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A technique of administering rifampicin over an extended period of time, with reduced side effects. A medicine that is for nasal administration and is used to prevent or treat neurodegenerative diseases, contains a rifampicin selected from the group consisting of rifampicin, derivatives thereof, and salts thereof, and a resveratrol selected from resveratrol and derivatives...